<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00680940</url>
  </required_header>
  <id_info>
    <org_study_id>CR-60/7260</org_study_id>
    <nct_id>NCT00680940</nct_id>
  </id_info>
  <brief_title>A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer</brief_title>
  <acronym>NSCLC</acronym>
  <official_title>Open Label, Randomized Multicentric Phase II Clinical Trial of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel and Cisplatin in Advanced Non Small Cell Lung Cancer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cadila Pharnmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cadila Pharnmaceuticals</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Mycobacterium w in combination with
      Paclitaxel plus Cisplatin are effective in Advanced Non Small Cell Lung cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Non-small cell lung cancer (NSCLC) accounts for 75% of all lung cancers. majority of patients
      of NSCLC patients are stage IIIA or IIIB patients are suitable for radiotherapy, which could
      not improve the survival rates of 5-10%. This study proposed Mycobacterium w (heat killed) in
      combination chemotherapy of Cisplatin and Paclitaxel along with radiotherapy for adjuvant
      therapy management of NSCLC in controlled clinical trial, which may prove the efficacy,
      better survival rate and quality of life.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival time of patients, quality of life</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Response rate, Hematological toxicity</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">221</enrollment>
  <condition>Non Small Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Chemotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Paclitaxel + Cisplatin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chemoimmunotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Paclitaxel + Cisplatin + Mycobacterium w</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paclitaxel &amp; Cisplatin</intervention_name>
    <description>Chemotherapeutic agent</description>
    <arm_group_label>Chemotherapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Mycobacterium w.</intervention_name>
    <description>Immunomodulator</description>
    <arm_group_label>Chemoimmunotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ability to understand and the willingness to sign a written informed consent document.

          -  Histologically or cytologically confirmed Non-Small Cell Cancer, Stage IIIB or IV.

          -  Age should be 18 years or above.

          -  ECOG should be in 0-1 range.

          -  Absolute neutrophil count ≥ 1,00,000/mm3

          -  hemoglobin ≥ 9.0g/dL

          -  AST and ALT ≤ 2.5 times upper limit of normal (ULN)range of institution (5times ULN if
             liver metastasis present).

          -  bilirubin not greater than 1.5 times ULN range of institution (3 times ULN if liver
             involvement).

          -  Creatinine ≤ upper limit of normal (ULN) range of institution.

          -  Negative pregnancy test for women of child bearing potential prior to entry into the
             trial.

        Exclusion Criteria:

          -  Patient who have cytotoxic chemotherapy or radiotherapy prior to entering the study

          -  Patient with systematic brain metastasis.

          -  History of allergic reaction attributed to paclitaxel, cisplatin or mycobacterium w or
             any of their ingredients.

          -  Pregnant women or nursing women.

          -  Uncontrolled intercurrent illness that would limit compliance with study requirements.

          -  HIV positive patients.

          -  Previous splenectomy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>R K Chaudhary, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Acharya Tulsi Regional Cancer Treatment &amp; Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rajeev Gupta, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Patel Hospital Pvt. Ltd.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anup Majumdar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Post Graduate Medical Education &amp; Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>A. Rajkumar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>V.N. Cancer Center GKNM Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rajeev Seam, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Regional Cancer center, Indira Gandhi Medical College</affiliation>
  </overall_official>
  <overall_official>
    <last_name>A.K. Patel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Choithram Hospital and Research Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chanchal Goswami, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>B.P.Poddar Hospital and Medical Research Ltd.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jaydip Biswas, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chittaranjan National Cancer Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ritwik Pandyea, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Netaji Subhash Chandra Bose Cancer Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aloke G Dastidar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bankura Sammilani Medical College</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Narayanankutty Warrier, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Malabar Institute of Medical Science (MIMS)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ashutosh N Aggarwal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Postgraduate Institute of Medical Education and Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Apurva Patel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gujarat Cancer &amp; Research Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Santanu Chaudhary, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>R.S.T. Cancer Hospital &amp; Research Centre</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rajeev Prasad, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Regional Cancer Centre, Indira Ghandhi Institute of Medical Science</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ramakrishna Malladi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MNJ Institute of Oncology, Regional Cancer Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gujarat Cancer &amp; Research Institute, New Civil Hospital Campus</name>
      <address>
        <city>Asarwa</city>
        <state>Ahmedabad</state>
        <zip>380013</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Cancer Center, Indira Gandhi Medical College</name>
      <address>
        <city>Shimla</city>
        <state>Himachal Pradesh</state>
        <zip>171001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MNJ Institute of Oncology, Regional Cancer Centre</name>
      <address>
        <city>Red Hills</city>
        <state>Hyderabad</state>
        <zip>500004</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Malabar Institute of Medical Science (MIMS)</name>
      <address>
        <city>Calicut</city>
        <state>Kerala</state>
        <zip>673016</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>B.P. Poddar Hospital and Medical Research Ltd.</name>
      <address>
        <city>New Alipore</city>
        <state>Kolkata</state>
        <zip>700053</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Choithram Hospital and Research Centre</name>
      <address>
        <city>Indore</city>
        <state>Madhya Pradesh</state>
        <zip>452014</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Cancer Centre, Indira Gandhi Institute of Medical Science</name>
      <address>
        <city>Sheikhpura</city>
        <state>Patna</state>
        <zip>800014</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Patel Hospital Pvt. Ltd</name>
      <address>
        <city>Jalandhar</city>
        <state>Punjab</state>
        <zip>144001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Acharya Tulsi Regional Cancer Treatment &amp; Research Institute</name>
      <address>
        <city>Bikaner</city>
        <state>Rajasthan</state>
        <zip>334003</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>V.N. Cancer Center, GKNM Hospital</name>
      <address>
        <city>Coimbatore</city>
        <state>TamilNadu</state>
        <zip>641037</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Netaji Subash Chandra Bose Cancer Research Institute</name>
      <address>
        <city>Kolkata</city>
        <state>West Bangal</state>
        <zip>700016</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bankura Sammilani Medical College</name>
      <address>
        <city>Gobindnagar</city>
        <state>West Bengal</state>
        <zip>722101</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Post Graduate Medical education &amp; Research</name>
      <address>
        <city>Kolkata</city>
        <state>West Bengal</state>
        <zip>700020</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chittaranjan National Cancer Institute</name>
      <address>
        <city>Kolkata</city>
        <state>West Bengal</state>
        <zip>700026</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2008</study_first_submitted>
  <study_first_submitted_qc>May 16, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2008</study_first_posted>
  <last_update_submitted>August 4, 2012</last_update_submitted>
  <last_update_submitted_qc>August 4, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>NSCLC</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
    <mesh_term>Mycobacterium Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
    <mesh_term>Cisplatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

